De Novo pediatric development of an antiviral drug product: A perspective from industry

Drug Information Journal

Volumn 33, Issue 2, 1999, Pages 397-405

  Rogers, Jon M ^a,b  

^a ViroPharma Incorporated   (United States)

^b NONE   (United States)

Author keywords

Enterovirus; Pediatrics; Picornavirus; Pleconaril; Rhinovirus

Indexed keywords

ANTIVIRUS AGENT; PLECONARIL;

DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG SENSITIVITY; DRUG TISSUE LEVEL; ENTEROVIRUS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032995312     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159903300211     Document Type: Review

References (38)

1. Morens DM. Enteroviral disease in early infancy. J Pediatrics. 1978;92:374-377.
2. Wilfert CM, Lehrman SN, Katz SL. Enteroviruses and meningitis. Pediatric Infect Dis. 1983;2:333-341.
3. Gwaltney GM, Ruckert RR. Rhinovirus. In: Richman DD, Whitley RJ, Hayden FG, ed. Clinical Virology. New York: Churchill Livingstone; 1997; 1025-1047.
4. McKinlay MA, Pevear DC, Rossmann MG. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Ann Rev Microbiology. 1992;46:635-654.
5. Smith TJ, Kremer MJ, Luo M, Vriend G, Arnold E, Kramer G, Rossmann MG, McKinlay MA, Diana G, Otto MJ. The site of attachment of human rhinovirus 14 and antiviral agents that inhibit uncoating. Science. 1986;233:1286-1293.
6. O'Connell J, Albin A, Blum D, Grint P, Schwartz J. Development of antiviral agents for picornavirus infections. In Rotbart HA, ed. Human Enterovirus Infections. Washington, DC: ASM Press; 1995;419-434.
7. Diana GD, Pevear DC. Antipicornavirus drugs: Current status. Antiviral Chemistry Chemother. 1997;8: 412-418.
8. Rogers JM, Diana GD, McKinlay MA. Pleconaril, a broad spectrum antipicornaviral agent. In Mills J, Corey L, eds. Antiviral Chemotherapy: New Directions for Clinical Application and Research. Englewood Cliffs, NJ: PTR Prentice-Hall; 1998.
9. Hayden FG, Andries A, Janssen PAJ. Safety and efficacy of oral pirodavir (R 77975) in experimental rhinovirus infection. Antimicrobial Agents Chemother. 1992;36:727-732.
10. Schiff GM, Sherwood JR, Young EC, Mason LJ. Prophylactic efficacy of WIN 54954 in prevention of experimental human coxsackievirus A21 infection and illness. Antiviral Res. 1992;17 (Suppl 1):92.
11. Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for the prophylaxis of experimental rhinovirus infection. Antimicrobial Agents Chemother. 1993;37:297-300.
12. Diana GD, Rudewicz P, Pevear DC, Nitz TJ, Aldous SC, et al. Picornavirus inhibitors: triflouromethyl substitution provides a global protective effect against hepatic metabolism. J Medicinal Chemistry. 1995;38:1355-1371.
13. Pevear DC, Seipel ME, Pallansch MA, McKinlay MA. In vitro activity of VP 63843 against field isolates of non-polio enteroviruses. H-99 Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 15-18, 1996.
14. Rotbart HA, Jones A, Novelli V, Blanche S, Webster ADB. Pleconaril treatment of chronic enteroviral central nervous system infections in children with agammaglobulinemia. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 28-October 1, 1997.
15. McKinney RA, Katz SL, Wilfert KM. Chronic enteroviral meningoencephalitis in agammagolbuliemic patients. Rev Infectious Dis. 1987;9:334-356.
16. Webster ADB, Rotbart HA, Warner T, Rudge P, Hyman N. Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction. Clinical Infectious Dis. 1993;17:657-661.
17. Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatric Infectious Dis J. 1993;12:820-824.
18. Jenista JA, Powell KR, Menegus MA. Epidemiology of neonatal enterovirus infection. J Pediatrics. 1984; 104:685-690.
19. Modlin JF. Perinatal echovirus infection: insights from a literature review of 61 cases. Western J Med. 1986;138:847-851.
20. Kearns GL, Bradley JS, Abdel-Rahman S, Jacobs RF. Pharmacokinetics of pleconaril in neonates. Submitted for presentation at the American Society of Clinical Pharmacology and Therapeutics, San Diego, CA June 6-11, 1999.
21. Johnson SL, et al. Community study of the role of viral infections of asthma in 9-11 year old children. Br Med J. 1995;310:1225-1228.
22. Nicholson KG, et al. Respiratory viruses and exacerbations of asthma in adults. Br Med J. 1991;307: 982-987.
23. Carlsen KH, et al. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Childhood. 1984;59:310-315.
24. Johnson SL. Natural and experimental rhinovirus infections of the lower respiratory tract. Am J Respiratory Critical Care Med. 1995;152:546-552.
25. Kearns GL. Introduction: Drug development for infants and children: Rescuing the therapeutic orphan. Drug Inf J. 1996;30:1121-1123.
26. Adler JL, et al. Epidemilogic investigation of hand, foot and mouth disease. Am J Dis Children. 1970; 120:309-131.
27. Hughes RO, et al. Hand, foot and mouth disease associated with coxsackie A9 virus. Lancet. 1972; 11:751-752.
28. Johnson JM, et al. Nosocomial outbreak of hand-foot- and-mouth disease among operating suite personnel. Infection Control. 1986;7:172-176.
29. Kimura AK, et al. Light and microscopic study of skin lesions of subjects with hand, foot and mouth disease. Tohoku J Experimen Med. 1977;122:237-247.
30. Lindenbaum JE, et al. Hand, foot and mouth disease associated with coxsackievirus group B. Scandinavian J Infectious Dis. 1975;7:161-163.
31. Miller GD, et al. Hand-foot- and mouth disease. JAMA. 1968;203:107-110.
32. Mukerji PS, et al. Hand, foot and mouth disease in two Edinburgh practices, 1980. J Royal Coll Gen Practitioners. 1982;32:366-368.
33. Nahmias AJ, et al. Generalized eruption in a child with eczema due to coxsackievirus A16. Arch Dermatol. 1968;97:147-148.
34. Robinson CR, et al. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957 - isolation of group A coxsackie virus. Canadian Med Assoc J. 1958;79:615-621.
35. Anonymous. Outbreak of hand, foot and mouth disease in Sarawak. Cluster of deaths among infants and young children. Weekly Epidemiolog Rev. 1997; 72:211-212.
36. Anonymous. Deaths among children during an outbreak of hand, foot and mouth disease - Taiwan, Republic of China, April-July 1998. Morbidity Mortality Weekly Report. 1998;47:629-632.
37. Kearns GL, Wells TG, et al. Pharmacokinetics of pleconaril in children. Abstract A-206. Presented at the 99th Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics. New Orleans, LA, March 30-April 1, 1998.
38. Shirkey H. Editorial comment: Therapeutic orphans. J Pediatrics. 1968;72:119-120.